FDA Action On Antidepressants Questioned; Congress Widens Investigation
Executive Summary
House and Senate Committees are requesting documentation from FDA officials on what and when they knew about a possible link between antidepressants and suicidal behavior
You may also be interested in...
FDA Employee Misconduct Charges To Be Investigated By OIG Instead Of Itself
A "stronger appearance of impartiality, integrity" will result from an HHS Office of Inspector General decision to take back investigative authority over allegations of employee misconduct at FDA, a GOP aide to the House Energy & Commerce Committee told "The Pink Sheet.
FDA Employee Misconduct Charges To Be Investigated By OIG Instead Of Itself
A "stronger appearance of impartiality, integrity" will result from an HHS Office of Inspector General decision to take back investigative authority over allegations of employee misconduct at FDA, a GOP aide to the House Energy & Commerce Committee told "The Pink Sheet.
Antidepressant Suicidality Needs Interim Risk Management, FDAer Maintains
FDA should establish an interim risk management plan to discourage pediatric antidepressant use, FDA epidemiologist Andrew Mosholder, MD, maintained in an Aug. 16 memo